In vivo regulation of vasomotricity by nitric oxide and prostanoids duringgestation

Citation
N. Boujedaini et al., In vivo regulation of vasomotricity by nitric oxide and prostanoids duringgestation, EUR J PHARM, 427(2), 2001, pp. 143-149
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
427
Issue
2
Year of publication
2001
Pages
143 - 149
Database
ISI
SICI code
0014-2999(20010914)427:2<143:IVROVB>2.0.ZU;2-X
Abstract
Pharmacological studies using the Doppler technique revealed that pregnancy decreases the systemic blood pressure and enhances uterine blood velocity in rats. The reactivity of the uterine artery to alpha -adrenoceptor and mu scarinic receptor agonists was higher than that of systemic arteries. Sodiu m nitroprusside increased uterine arterial blood velocity slightly during g estation and markedly in non-pregnant rats. N-G-L-Arginine methyl ester (L- NAME) decreased the uterine blood velocity mainly in gravid animals. The ef fect of diclofenac on uterine blood velocity was also more pronounced durin g pregnancy. The actions of sodium nitroprusside, L-NAME and diclofenac on systemic blood pressure were similar in pregnant and virgin rats. Altogethe r, these results indicate that pregnancy enhances nitric oxide (NO) and vas odilatory prostanoid production in the uterine vascular muscle which become s less sensitive to exogenous NO. The uterine vasodilated status appears to be determined by conjugated actions of endothelial NO and vasodilator pros tanoids of which the synthesis and the effects are weakly modified in syste mic arteries during gestation. (C) 2001 Elsevier Science B.V. All rights re served.